Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
676 rows where has_known_aptamer = 0, surface_class = "unknown" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total
tier 1
- Tier 1.5 · 676 ✖
surface_class 1
- unknown · 676 ✖
has_known_aptamer 1
- - · 676 ✖
has_activation_state_pdb_pair 1
- 0 676
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P06865 | Tier 1.5 | 0.759 | 1 | unknown | 2 | 93.44 | 0 | 0 | 0 | 0 | 1 | Tay-Sachs disease | 0.8629597356732491 | |||||
| P04275 | Tier 1.5 | 0.749 | 1 | unknown | 48 | 75.5 | 1 | 0 | 0 | 0 | 1 | Von Willebrand disease | 0.8296081124598669 | |||||
| P56589 | Tier 1.5 | 0.749 | 1 | unknown | 2 | 88.88 | 0 | 0 | 0 | 0 | 1 | Zellweger syndrome | 0.8285793075049609 | |||||
| P09603 | Tier 1.5 | 0.618 | 1 | unknown | 8 | 57.41 | 0 | 0 | 0 | 0 | 1 | type 2 diabetes mellitus | 0.39219340856589974 | |||||
| O75365 | Tier 1.5 | 0.612 | 1 | unknown | 4 | 86.88 | 0 | 0 | 0 | 0 | 1 | hypertension | 0.3732487322932303 | |||||
| Q5IJ48 | Tier 1.5 | 0.593 | 1 | unknown | 1 | 76.44 | 0 | 0 | 0 | 0 | 0 | ventriculomegaly-cystic kidney disease | 0.8112741813611002 | |||||
| P01185 | Tier 1.5 | 0.585 | 1 | unknown | 5 | 79.44 | 1 | 0 | 0 | 0 | 0 | neurohypophyseal diabetes insipidus | 0.7825664629740794 | |||||
| O15297 | Tier 1.5 | 0.583 | 1 | unknown | 1 | 67.88 | 0 | 0 | 0 | 0 | 0 | intellectual developmental disorder with gastrointestinal difficulties and high pain threshold | 0.7779617805712467 | |||||
| O60930 | Tier 1.5 | 0.574 | 1 | unknown | 7 | 79.56 | 0 | 0 | 0 | 0 | 0 | progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2 | 0.74733857283595 | |||||
| O60882 | Tier 1.5 | 0.568 | 1 | unknown | 1 | 83.31 | 0 | 0 | 0 | 0 | 0 | Hypomaturation amelogenesis imperfecta | 0.7281006394540224 | |||||
| O75838 | Tier 1.5 | 0.564 | 1 | unknown | 1 | 88.62 | 0 | 0 | 0 | 0 | 0 | hearing loss, autosomal recessive | 0.7117048435819099 | |||||
| P07305 | Tier 1.5 | 0.562 | 1 | unknown | 16 | 68.75 | 1 | 0 | 0 | 0 | 1 | open-angle glaucoma | 0.2081722206162343 | |||||
| Q5SWA1 | Tier 1.5 | 0.54 | 1 | unknown | 5 | 49.03 | 1 | 0 | 0 | 0 | 0 | microcephaly, short stature, and impaired glucose metabolism 2 | 0.6334721902580683 | |||||
| O43543 | Tier 1.5 | 0.529 | 1 | unknown | 16 | 87.12 | 1 | 0 | 0 | 0 | 0 | spermatogenic failure 50 | 0.5955217891975265 | |||||
| G2XKQ0 | SUMO1P1 | Small ubiquitin-related modifier 5 | Tier 1.5 | 0.5 | 1 | unknown | 1 | 79.81 | 0 | 0 | 0 | 0 | 1 | |||||
| P79483 | HLA-DRB3 | HLA class II histocompatibility antigen, DR beta 3 chain | Tier 1.5 | 0.5 | 1 | unknown | 2 | 88.38 | 0 | 0 | 0 | 0 | 1 | |||||
| P01579 | Tier 1.5 | 0.498 | 1 | unknown | 8 | 85.31 | 0 | 0 | 0 | 0 | 0 | Primary hemophagocytic lymphohistiocytosis | 0.49197933519665166 | |||||
| Q6NW34 | RMP64 | Ribonuclease MRP subunit P64 | Tier 1.5 | 0.485 | 1 | unknown | 3 | 64.0 | 1 | 0 | 0 | 0 | 0 | anauxetic dysplasia 3 | 0.44914218451265836 | |||
| O95352 | Tier 1.5 | 0.484 | 0 | unknown | 0 | 87.62 | 0 | 0 | 0 | 0 | 1 | spinocerebellar ataxia, autosomal recessive 31 | 0.7618016657355056 | |||||
| Q5TAT6 | Tier 1.5 | 0.481 | 0 | unknown | 0 | 55.59 | 0 | 0 | 0 | 0 | 1 | Congenital myasthenic syndromes | 0.7544056165993482 | |||||
| P48509 | Tier 1.5 | 0.473 | 0 | unknown | 0 | 88.25 | 0 | 0 | 0 | 0 | 1 | epidermolysis bullosa simplex 7, with nephropathy and deafness | 0.7253740723597262 | |||||
| Q32NC0 | RMP24 | Ribonuclease MRP protein subunit p24 | Tier 1.5 | 0.43 | 1 | unknown | 3 | 74.06 | 1 | 0 | 0 | 0 | 0 | connective tissue disease | 0.2652381012117321 | |||
| Q9NY61 | Tier 1.5 | 0.424 | 1 | unknown | 3 | 64.81 | 1 | 0 | 0 | 0 | 0 | skin neoplasm | 0.24706398094697377 | |||||
| P34910 | Tier 1.5 | 0.38 | 0 | unknown | 0 | 50.94 | 0 | 0 | 0 | 0 | 1 | neurofibromatosis type 1 | 0.4178305579352045 | |||||
| O60941 | Tier 1.5 | 0.377 | 0 | unknown | 0 | 75.38 | 0 | 0 | 0 | 0 | 1 | cutaneous melanoma | 0.4068656041128879 | |||||
| Q5I7T1 | Tier 1.5 | 0.375 | 0 | unknown | 0 | 93.0 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.4010039380812394 | |||||
| Q5SR56 | SLC71A2 | Solute carrier family 71 member 2 | Tier 1.5 | 0.372 | 0 | unknown | 0 | 76.75 | 0 | 0 | 0 | 0 | 1 | atrial fibrillation | 0.3910715051744718 | |||
| P49842 | WHR1 | Winged helix repair factor 1 | Tier 1.5 | 0.361 | 1 | unknown | 5 | 87.44 | 1 | 0 | 0 | 0 | 0 | melanoma | 0.036990092138582946 | |||
| Q9H8H3 | TMT1A | Thiol S-methyltransferase TMT1A | Tier 1.5 | 0.358 | 0 | unknown | 0 | 96.12 | 0 | 0 | 0 | 0 | 1 | heart failure | 0.3434183182553741 | |||
| O15232 | Tier 1.5 | 0.354 | 0 | unknown | 0 | 79.38 | 0 | 0 | 0 | 0 | 0 | multiple epiphyseal dysplasia type 5 | 0.8302929519450023 | |||||
| O95343 | Tier 1.5 | 0.35 | 0 | unknown | 0 | 67.88 | 0 | 0 | 0 | 0 | 0 | holoprosencephaly | 0.8181248878625513 | |||||
| P49326 | Tier 1.5 | 0.349 | 0 | unknown | 0 | 94.94 | 0 | 0 | 0 | 0 | 1 | type 2 diabetes mellitus | 0.3139213554354413 | |||||
| O95741 | Tier 1.5 | 0.267 | 0 | unknown | 0 | 86.38 | 0 | 0 | 0 | 0 | 1 | glioblastoma multiforme | 0.03986072724380628 | |||||
| A3KN83 | Tier 1.5 | 0.255 | 0 | unknown | 0 | 67.31 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.49840530754835893 | |||||
| Q9BYX7 | POTEKP | Putative beta-actin-like protein 3 | Tier 1.5 | 0.255 | 0 | unknown | 0 | 94.81 | 0 | 0 | 0 | 0 | 1 | |||||
| A6NMY6 | ANXA2P2 | Putative annexin A2-like protein | Tier 1.5 | 0.255 | 0 | unknown | 0 | 94.25 | 0 | 0 | 0 | 0 | 1 | |||||
| Q3KR37 | Tier 1.5 | 0.248 | 0 | unknown | 0 | 67.5 | 0 | 0 | 0 | 0 | 0 | chronic lymphocytic leukemia | 0.47654335621881755 | |||||
| O43439 | Tier 1.5 | 0.242 | 0 | unknown | 0 | 63.69 | 0 | 0 | 0 | 0 | 0 | Abnormality of the skeletal system | 0.45637506575193026 | |||||
| Q14147 | Tier 1.5 | 0.24 | 0 | unknown | 0 | 80.5 | 0 | 0 | 0 | 0 | 0 | Neurodevelopmental disorder | 0.4499737391856989 | |||||
| Q96LM5 | SPMIP2 | Protein SPMIP2 | Tier 1.5 | 0.232 | 0 | unknown | 0 | 62.75 | 0 | 0 | 0 | 0 | 0 | Abnormality of the skeletal system | 0.4220350712092463 | |||
| O94964 | MTCL2 | Microtubule cross-linking factor 2 | Tier 1.5 | 0.221 | 0 | unknown | 0 | 54.25 | 0 | 0 | 0 | 0 | 0 | skin cancer | 0.38790668759818864 | |||
| Q53TS8 | CATSPERT | Cation channel sperm-associated targeting subunit tau | Tier 1.5 | 0.22 | 0 | unknown | 0 | 39.66 | 0 | 0 | 0 | 0 | 0 | male infertility due to globozoospermia | 0.3830436487908655 | |||
| Q6P4F1 | POFUT3 | GDP-fucose protein O-fucosyltransferase 3 | Tier 1.5 | 0.218 | 0 | unknown | 0 | 87.94 | 0 | 0 | 0 | 0 | 0 | Abnormality of the skeletal system | 0.377894214690425 | |||
| Q6UWJ1 | SLC9D1 | Solute carrier family 9 member D1 | Tier 1.5 | 0.209 | 0 | unknown | 0 | 75.94 | 0 | 0 | 0 | 0 | 0 | Anxiety | 0.3453798727200914 | |||
| Q14802 | Tier 1.5 | 0.206 | 0 | unknown | 0 | 68.25 | 0 | 0 | 0 | 0 | 0 | Hypomyelination neuropathy - arthrogryposis | 0.3360486957577248 | |||||
| Q2TAC6 | Tier 1.5 | 0.205 | 0 | unknown | 0 | 64.62 | 0 | 0 | 0 | 0 | 0 | Non-immune hydrops fetalis | 0.3326218692162316 | |||||
| Q13491 | Tier 1.5 | 0.199 | 0 | unknown | 0 | 82.31 | 0 | 0 | 0 | 0 | 0 | open-angle glaucoma | 0.31489783643542385 | |||||
| Q9HAT0 | Tier 1.5 | 0.191 | 0 | unknown | 0 | 85.25 | 0 | 0 | 0 | 0 | 0 | Vitiligo | 0.28500489474800955 | |||||
| O95447 | Tier 1.5 | 0.187 | 0 | unknown | 0 | 62.31 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.27241083934376026 | |||||
| Q9BSJ5 | MTNAP1 | Mitochondrial nucleoid-associated protein 1 | Tier 1.5 | 0.186 | 0 | unknown | 0 | 44.44 | 0 | 0 | 0 | 0 | 0 | exostosis | 0.270767386991046 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;